M1 Kliniken AG: Strong earnings growth in 2024 - focus on global market leadership EQS News: M1 Kliniken AG / Key word(s): Annual Report/Dividend M1 Kliniken AG: Strong earnings growth in 2024 - focus on global market leadership 21.05.20...

M1 Kliniken AG: Strong earnings growth in 2024 – global market leadership in focus

 EQS News: M1 Kliniken AG / Key word(s): Annual Report/Dividend
M1 Kliniken AG: Strong earnings growth in 2024 - worldwide
Focus on market leadership

21.05.2025 / 08:30 CET/CEST
The issuer/publisher is responsible for the content of this announcement.

---------------------------------------------------------------------------

M1 Kliniken AG: Strong earnings growth in 2024 - worldwide
Focus on market leadership

Berlin, 21.05.2025 - M1 Kliniken AG (ISIN: DE000A0STSQ8) today announced its
Annual Report for 2024 published. Last year
The M1 Group continued its growth course - driven primarily by
high-margin beauty segment. The company also sees growth in the coming years
Company significant growth potential: Sales in the beauty segment
are expected to rise to 200 to 300 million euros by 2029 with an EBIT margin of
at least 20%. The aim is to make M1 Med Beauty the world's leading
brand for cosmetic medical treatments. Today,
M1 market leader in Europe - with the highest quality standards at the best price.
With the dividend proposal of EUR 0.50 per share, the Management Board and
Supervisory Board the company’s distribution policy.

Key figures at a glance

* Group sales increase by 7% to EUR 339.2 million (previous year: EUR 316.3 million)

* EBITDA increases by 52% to EUR 32.0 million (previous year: EUR 21.0 million)

* EBIT increased by 70% to EUR 26.8 million (previous year: EUR 15.7 million)

* EBT increases by 60% to EUR 26.3 million (previous year: EUR 16.4 million)

* Beauty segment grows by 30% to EUR 91.7 million (previous year: EUR 70.8 million)

* Equity ratio: increase from 67% to 71%

Profitability and cash flow increase significantly

Consolidated net profit after minority interests increased significantly in 2024 to
16.0 million euros (previous year: 10.3 million euros). This corresponds to an increase of
Earnings per share increased from EUR 0.54 to EUR 0.85. Operating cash flow
increased to EUR 30.5 million (previous year: EUR 7.8 million), free cash flow to
24.9 million euros - after -1.5 million euros in the previous year.

The 2024 Annual Report is available for download at www.m1-kliniken.de
Disposal.

About M1 Kliniken AG

M1 Kliniken AG is the leading fully integrated provider
cosmetic health services in Europe. In
aesthetic and surgical area, the group offers
Products and services with the highest quality standards. Under the
Brand "M1 Med Beauty" is currently available at 58 specialist centers in 10 countries
cosmetic medical treatments are offered.
M1-Schlossklinik for plastic and aesthetic surgery in Berlin with
six operating rooms and 35 beds, it is one of the largest and most modern
facilities of this kind in Europe. Since the end of 2018, M1 has been driving the
Internationalization and is currently represented in ten countries.




Contact:
M1 Clinics AG
Grünauer Straße 5
12557 Berlin
Telephone: +49 (0)30 347 47 44 14
Email: [email protected]


---------------------------------------------------------------------------

21.05.2025 CET/CEST Publication of a corporate news/financial news,
transmitted by EQS News - a service of the EQS Group.
The issuer/publisher is responsible for the content of this announcement.

The EQS Distribution Services include statutory reporting obligations, corporate
News/financial news and press releases.
Media archive at https://eqs-news.com

---------------------------------------------------------------------------

Language: German
Company: M1 Kliniken AG
Grünauer Straße 5
12557 Berlin
 Germany
 Telephone: +49 (0)30 347 47 44 14
Fax: +49 (0)30 347 47 44 17
Email: [email protected]
 Internet: https://www.m1-kliniken.de
ISIN: DE000A0STSQ8
WKN: A0STSQ
Stock exchanges: Open market in Berlin, Düsseldorf, Frankfurt (Basic
Board), Hamburg, Hanover, Munich, Stuttgart,
Tradegate Exchange
EQS News ID: 2141988



End of message EQS News Service
---------------------------------------------------------------------------

2141988 21.05.2025 CET/CEST